Inhibition of ERK activation in the retina by its specific inhibitor U0126 blocks the actions of diabetes that causes upregulation of VEGF and inflammatory biomarkers, suggesting that ERK activation is involved in the pathogenesis of diabetic retinal dysfunction [37, 38]. This evidence concerns the gene VEGFA and diabetes mellitus.